Mentor, Ohio (June 16, 2011) – For convenient ocular imaging in any setting, Volk Optical’s new truly portable Pictor digital device enables ophthalmic imaging not possible with traditional fixed systems. The Pictor delivers high resolution images of t…
Category: News
U.S. Advisers Back Regeneron Eye Drug
A new eye medicine from Regeneron Pharmaceuticals Inc and Bayer AG is safe and effective for treating a common cause of vision loss, a panel of U.S. experts said on Friday.
Dense Brunescent Cataracts Present Surgical Challenges
Among the most difficult cases for phacoemulsification is the dense brunescent cataract. Due to the increased nuclear density, the cataract surgery requires more effort, energy and attention to successfully complete. The patients are at a higher risk f…
Severe Complications From Cataract Surgery Decline
Serious, potentially blinding complications from cataract eye surgery are uncommon, and have been declining since the 1990s, a new U.S. study finds.
DRY EYE: AWARD WINNING TECHNOLOGY SOLVES DILEMMA FOR PATIENTS Ardeo HealthT Licenses New Dry Eye Therapy From Novagali Pharma
Suwanee, GA, USA (June 15, 2011) – Ardeo Health, LLC, a biopharmaceutical development and licensing company, announced today that it has reached an agreement with Novagali Pharma S.A. of Evry, France to license Novagali’s novel Nova23041 dry eye therap…
$3 Million Award To Develop Gene, Stem Cell Therapies For Common Eye Complication Of Diabetes
Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that ca…
Regeneron Announces EYLEAâ„¢ (aflibercept Ophthalmic Solution) Receives Unanimous Recommendation For Approval For Treatment Of Wet AMD From FDA
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S…
ACT Announces First Patients Enrolled In Two Clinical Trials Using Embryonic Stem Cells To Treat Stargardt’s Disease
Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular…
ACOs: Shared Savings and Improved Care, Says Don Berwick
Donald M. Berwick, MD, MPP, of CMS describes the structure of accountable care organizations and how they are designed to improve patient care. Government Perspectives on Healthcare
VEGF Trap-Eye For Wet Age-related Macular Degeneration Unanimously Approved By FDA Panel
VEGF Trap-Eye, used for the treatment of the neovascular form of age-related macular degeneration (wet AMD), a condition that can lead to blindness, has been approved by a 10 to 0 FDA Panel vote. The treatment is approved for administration every other…
Regeneron Announces EYLEA (aflibercept Ophthalmic Solution) Receives Unanimous Recommendation For Approval For Treatment Of Wet AMD From FDA Advisory Committee
Regeneron Pharmaceuticals, Inc. today announced that the Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend that the FDA approve EYLEA, also known as VEGF Trap-Eye, for…
Sight Restored After 55 Years
Surgery has restored sight in the eye of a man who for 55 years had a detached retina that left him blind in his right eye after it was hit by a stone when he was 8 years old…
Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease
Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that ca…
Regeneron Drug Effectively Treats Vision Loss: FDA Documents
U.S. drug reviewers have said an investigational eye medicine called VEGF Trap-Eye from Regeneron Pharmaceuticals and Bayer AG is effective against the wet form of age-related macular degeneration, raising expectations it will be recommended for approv…
Intravitreal Anti-VEGF Improves Vision In Diabetic Macular Edema Patients
Intravitreal pegaptanib resulted in significantly improved vision in patients with diabetic macular edema, making it an effective, well-tolerated treatment option, a study found.
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
Single-Piece IOLs May Cause Secondary Glaucoma
Single-piece acrylic IOLs that are malpositioned may cause glaucoma that is often not attributed to the IOL, according to a speaker here.
After 55 Years, Surgery Restores Sight
After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye. Doctors at …